A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
Nicolas Béry(John Radcliffe Hospital), Terence H. Rabbitts(Institute of Cancer Research)
Cited by 128
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.
|Proceedings of the National Academy of Sciences|1991|371
Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment
|Nature Communications|2018|131